Authors: Debrix, I Tilleul, P Milleron, B Grene, N Bouleuc, C Roux, D Liote, H Madelaine, I Bellanger, A Conort, O Fontan, JE Le Mercier, F Bardin, C Becker, A

Citation: I. Debrix et al., The relationship between introduction of American Society of Clinical Oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital, CLIN THER, 23(7), 2001, pp. 1116-1127

Authors: Faivre, L Saoudi, S Astier, A Hamadas, C Conort, O Boivin, H Sabatier, B Taburet, AM Lecointre, K Bellanger, A Radideau, E Thuillier, A

Citation: L. Faivre et al., FK 506 dose in transplantation: From theory to practice, TRANSPLAN P, 33(4), 2001, pp. 2594-2597

Authors: Ripouteau, C Conort, O Lamas, JP Auleley, GR Hazebroucq, G Durieux, P

Citation: C. Ripouteau et al., Quality improvement report - Effect of multifaceted intervention promotingearly switch from intravenous to oral acetaminophen for postoperative pain: controlled, prospective, before and after study, BR MED J, 321(7274), 2000, pp. 1460-1463

Authors: Grene, N Pointereau-Bellanger, A Conort, O Fontan, JE Le Mercier, F Madelaine, I Bardin, C Roux, D Debrix, I Tilleul, P

Citation: N. Grene et al., Multicenter study of the impact of prescription guidelines on the use of colony stimulating factors, ANTI-CANC D, 11(2), 2000, pp. 109-115

Authors: Fagot, JP Flahault, A Kanfer, A Benoit, G Bellanger, A Conort, O Durand-Zaleski, I Liote, H Mangin, L Oliary, J Verdy, E Becker, A

Citation: Jp. Fagot et al., Prevention of venous thromboembolism in patients hospitalized for more than 24 hours in a medical ward: proposed indications for low molecular weightheparins, PRESSE MED, 29(1), 2000, pp. 4-10